SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-14-000009
Filing Date
2014-02-25
Accepted
2014-02-25 16:12:42
Documents
3
Period of Report
2014-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a4q13form8-k.htm 8-K 38481
2 EX-99.1 a4q13financialpr.htm EX-99.1 452258
3 GRAPHIC jazzlogo1.jpg GRAPHIC 26766
  Complete submission text file 0001232524-14-000009.txt   529181
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 14640762
SIC: 2834 Pharmaceutical Preparations